Financials in USD. Standardized financial statements.
A compact view of how BioDelivery Sciences International, Inc. turns revenue into operating income and net income.
| Metric | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $166.70M | $156.47M | $111.39M | $55.64M | $61.98M | $15.55M | $48.23M | $38.94M | $11.36M | $54.54M |
| Revenue Growth? | +6.5% | +40.5% | +100.2% | -10.2% | +298.7% | -67.8% | +23.8% | +242.9% | -79.2% | 0.0% |
| Cost of Revenue? | $23.37M | $24.66M | $21.59M | $15.78M | $19.50M | $11.26M | $8.10M | $4.94M | $2.08M | $1.91M |
| Gross Profit? | $143.33M | $131.81M | $89.80M | $39.86M | $42.49M | $4.29M | $40.13M | $34.01M | $9.27M | $52.63M |
| Gross Margin? | +86.0% | +84.2% | +80.6% | +71.6% | +68.5% | +27.6% | +83.2% | +87.3% | +81.7% | +96.5% |
| Operating Expenses? | $106.21M | $98.83M | $86.06M | $63.51M | $71.91M | $68.22M | $75.31M | $72.75M | $65.68M | $45.57M |
| Operating Income? | $37.12M | $32.98M | $3.74M | -$23.65M | -$29.42M | -$63.94M | -$35.18M | -$38.74M | -$56.40M | $7.06M |
| EBITDA? | $44.54M | $40.49M | $12.57M | -$17.77M | $4.01M | -$62.46M | -$33.85M | -$51.11M | -$55.14M | $8.58M |
| Income Before Tax | $29.62M | $25.96M | -$15.30M | -$33.85M | -$10.69M | -$67.14M | -$37.67M | -$54.22M | -$57.39M | $1.78M |
| Income Tax Expense | -$55.24M | $252,000 | $5,000 | $13,000 | -$15.97M | $64,000 | $25,000 | $0 | -$89,014 | $129,120 |
| Net Income? | $84.86M | $25.71M | -$15.30M | -$33.87M | $5.29M | -$67.14M | -$37.67M | -$54.22M | -$57.39M | $1.65M |
| EPS? | $0.82 | $0.26 | $-0.18 | $-0.54 | $0.10 | $-1.25 | $-0.72 | $-1.12 | $-1.51 | $0.05 |
| Diluted EPS? | $0.82 | $0.24 | $-0.18 | $-0.54 | $0.09 | $-1.25 | $-0.72 | $-1.12 | $-1.51 | $0.05 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality